Abstract
In this issue of Cell Metabolism, Hochrein et al. identify a metabolic checkpoint controlling the transcriptional programming of effector CD4+ T cells. The authors show that GLUT3-mediated glucose import and ACLY-dependent acetyl-CoA generation control histone acetylation and, hence, the epigenetic imprinting of effector gene expression in differentiated effector CD4+ T cells. These findings suggest a novel therapeutic target for inflammation-associated diseases.
| Original language | English |
|---|---|
| Pages (from-to) | 503-505 |
| Number of pages | 3 |
| Journal | Cell Metabolism |
| Volume | 34 |
| Issue number | 4 |
| DOIs |
|
| Publication status | Published - 5 Apr 2022 |